Second primary cutaneous melanoma in patients with advanced melanoma treated with anti-programmed-death-receptor-1 monoclonal antibodies

Br J Dermatol. 2021 Apr;184(4):746-748. doi: 10.1111/bjd.19629. Epub 2020 Dec 1.

E Charvet¹, N Kramkimel², L Chaplain^{1

3}, A Gantzer¹, O Kassem¹, C Longvert^{1

3}, A Blom^{1

3}, N Dupin², S Aractingi², M Hamon⁴, U Zimmermann⁴, J-F Emile^{3

4}, P Sohier⁵, T Sidibé⁶, P Saiag^{1

3}, E Funck-Brentano^{1

3}

¹ Departments of, Department of, General and Oncologic Dermatology, Ambroise-Paré Hospital, AP-HP, Boulogne-Billancourt, France.
² Departments of, Department of, Dermatology, Cochin Hospital, AP-HP, Paris, France.
³ EA 4340 'Biomarkers and Clinical Trials in Cancerology and Hemato-oncology', UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France.
⁴ Department of, Pathology, Ambroise-Paré Hospital, AP-HP, Boulogne-Billancourt, France.
⁵ Department of, Pathology, Cochin Hospital, AP-HP, Paris, France.
⁶ Department of, Pharmacy, Ambroise-Paré Hospital, AP-HP, Boulogne-Billancourt, France.

No abstract available

Publication types